Trusts launch medicines waste campaign

A host of NHS trusts across south east London have launched a new medicines management campaign to combat widespread drug waste and treatments being misused or taken incorrectly.

Commissioning Board publishes CCG running costs allowances

The NHS Commissioning Board has published revised running costs allowances (RCAs) for the 211 Clinical Commissioning Groups (CCGs) in 2013/14.

Type 1 diabetes patients are denied access to NHS specialists

NHS commissioning policies stop people with type 1 diabetes from gaining access to essential specialist services, medical experts have warned.

Final CCGs submit applications

The final ‘wave’ of clinical commissioning groups have submitted their applications for authorisation with the NHS Commissioning Board (NHS CB).

Bridge over troubled healthcare

How will Public Health England bring together the NHS and local government?

CQC improving after difficult start

The Care Quality Commission has experienced “serious difficulties” in its first 18 months, according to a National Audit Office report.

NICE launches QOF consultation

The National Institute of Health and Clinical Excellence (NICE) has launched a public consultation on the new indicators for the 2013/14 Quality and Outcomes Framework (QOF).

Public ignoring flu jab

The Government has claimed people who ignore receiving the seasonal flu vaccine are playing “Russian roulette with their lives”.

New online register launched by EMA and ENCePP

The EMA and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) have launched the E-Register of Studies.

The new UK pharma Code

Dr Powar asks how the changes to the ABPI Code will impact pharma's customer relationships.

Latest articles

IMBRUVICA® misses primary endpoint in pancreatic cancer trial

IMBRUVICA® misses primary endpoint in pancreatic cancer trial

AbbVie have released an update on the RESOLVE trial of IMBRUVICA® in combination with chemotherapy agents in metastatic pancreatic cancer.  AbbVie, a research-based global biopharmaceutical company,...
Star Europe reports positive client and candidate feedback.

Star Europe’s Amsterdam office off to positive start

Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
ORKAMBI® for cystic fibrosis

EC approves Vertex’s ORKAMBI® for cystic fibrosis patients

Vertex Pharmaceuticals announces that the European Commission has granted approval of the label extension for ORKAMBI® for cystic fibrosis patients.  The European Commission has granted approval...